Capsule Commentary on Phibbs et. al., At-Home versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS)

Por Canestaro, William J.
Publicado no J Gen Intern Med (2016)

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review

Por Canestaro, William J., Austin, Melissa A., Thummel, Kenneth E.
Publicado no Genet Med (2014)

Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use

Por Chin, Lauren, Devine, Beth, Baradaran, Sarah, Keyloun, Katelyn, Canestaro, William, Pham, Jonathan
Publicado no AMIA Jt Summits Transl Sci Proc (2017)

Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing

Por Canestaro, William J., Brooks, David G., Chaplin, Donald, Choudhry, Niteesh K., Lawler, Elizabeth, Martell, Lori, Brennan, Troyen, Wassman, E. Robert
Publicado no J Pers Med (2012)